Add this topic to your myFT Digest for news straight to your inbox
Republican and Democratic senators accuse industry intermediaries of harming consumers
Tobacco stocks move lower on fears regulator’s tough push against ecigarettes will continue
Commissioner had locked horns with the tobacco industry over ecigarettes
Politicians to grill pharma executives over what is fast becoming a key election issue
Donald Trump is no longer listening to big business
Pharmaceutical giant backed down on July increases but will go ahead in January
Fighting high drug prices, ‘legal highs’ and psychedelic science
The public-private NHS, Russian anti-vaxx bots, the burden of booze
The US needs a health secretary with the mettle to enact painful industry reforms
Ian Read’s decision to lift drug prices was a political misjudgment — and not his first
Pfizer faced presidential fire for its price rises but others use more subtle tactics
As overdose numbers soar, many experts are recommending medication over abstinence
Takeda chief on Shire purchase, NHS finances, health warnings with teeth
President stops short of measures that would crimp US pharmaceutical profits
US president expected to outline plans in speech to lower drug prices
Flu victim should have paid much less for her medication, data show
CDC director says ‘certain complex financial interests’ limit her ability to do job
Ann Aerts, drugmaker deal frenzy, India’s ‘menstrual man’
Natalia Kanem, child mortality and the rise of the robots
International Edition